https://www.marketprism.co/blog/2026-09-25-novo-nordisk-assessing-the-structural-discount-in-a-contested-glp-1-market Market Prism en 2026-09-25T16:12:13.596Z Novo Nordisk: Assessing the Structural Discount in a Contested GLP-1 Market NVO, Research, market analysis, narrative intelligence https://www.marketprism.co/og-image/2026-09-25-novo-nordisk-assessing-the-structural-discount-in-a-contested-glp-1-market Novo Nordisk: Assessing the Structural Discount in a Contested GLP-1 Market https://www.marketprism.co/blog/2026-09-24-gis-q1-earnings-forensic Market Prism en 2026-09-24T14:32:07.372Z GIS Q1 FY2027 Forensic Report: Modest Beat Masks Structural Pressure as Margins Hold the Line GIS, Post-Earnings, market analysis, narrative intelligence https://www.marketprism.co/og-image/2026-09-24-gis-q1-earnings-forensic GIS Q1 FY2027 Forensic Report: Modest Beat Masks Structural Pressure as Margins Hold the Line